Prospective, Multicentre, Non-interventional (Observational) Study of VANTAS for the Treatment of Patients With Advanced Prostate Cancer.

Trial Profile

Prospective, Multicentre, Non-interventional (Observational) Study of VANTAS for the Treatment of Patients With Advanced Prostate Cancer.

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Oct 2014

At a glance

  • Drugs Histrelin (Primary)
  • Indications Prostate cancer
  • Focus Therapeutic Use
  • Sponsors Orion Pharma
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 15 Oct 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 11 Jan 2013 Planned End Date (Jun 2014) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top